On Monday, investor focus in the equity market will centre on IPO listings, quarterly earnings and corporate developments. Lodha Developers, Apollo Hospitals and Hindustan Copper are among the stocks expected to remain in focus.
Fractal Analytics and Kwality Walls IPO listings, January WPI inflation data and company-specific corporate triggers will guide market activity during the session.
Lodha Developers has entered into an agreement to acquire an 80 percent stake in Pune-based Solidrise Realty (SRPL) for Rs 294 crore. Following completion of the transaction, SRPL will become a subsidiary of the company.
Apollo Hospitals’ interim dividend has its ex-date today. The company has declared an interim dividend of Rs 10 per share. Shareholders purchasing the stock up to the ex-date will be eligible for the dividend.
Fractal Analytics is scheduled to list on the stock exchanges today. The IPO was subscribed 2.66 times overall. Qualified Institutional Buyers subscribed 4.18 times, Non-Institutional Investors 1.06 times and retail investors 1.03 times.
The Reserve Bank of India has granted final approval to BC Asia Investments XXV and BC Asia Investments XIV to acquire up to 41.66 percent equity and convertible instruments in Manappuram Finance.
Ashoka Buildcon has received a Letter of Acceptance from Liberia’s Public Works Ministry for a road upgradation project valued at $45.27 million. The project includes upgradation of roads from Nrowkia (Sasstown Junction) to Barclayville and from Nrowkia (Sasstown Junction) to Sasstown.
Aurobindo Pharma’s subsidiary Acrotech Biopharma Inc. has received approval from the US Food and Drug Administration for its New Drug Application for ADQUEY (difamilast 1%) ointment, indicated for the treatment of mild to moderate atopic dermatitis.
Jubilant HollisterStier General Partnership’s Montreal Contract Manufacturing Facility was classified as Official Action Indicated by the US Food and Drug Administration following an audit conducted in October and November 2025. The company stated that corrective actions have been implemented and production has resumed.
NBCC reported mixed results for Q3FY26. Revenue increased 7.6 percent, while profit after tax rose 39 percent. EBITDA and margins declined. The company stated that work on RERA-approved projects in Jammu and Kashmir will commence soon.
Zydus Lifesciences has received final approval from the US Food and Drug Administration for Ammonium Lactate Cream 12%, indicated for the treatment of dry and rough skin.
Torrent Pharmaceuticals reported Q3FY26 results that were ahead of expectations, supported by growth in India, the United States and Brazil.
The Jharkhand government has issued a recovery notice of Rs 929.4 crore to Hindustan Copper, alleging that the company did not obtain valid permissions or exceeded permitted production limits at the Surda mine. The company has denied the allegations and is pursuing legal action.
Indigo Paints reported Q3FY26 results with increases in EBITDA and margins, while profit after tax recorded a marginal rise.
Religare Enterprises and Religare Finvest have approved a demerger under which the financial services and insurance businesses will be separated into independently listed companies. Religare Finvest will issue shares to its shareholders in a 1:1 ratio.
Mercer QIF Fund Plc sold 19.04 lakh shares of Honasa Consumer, representing a 0.58 percent stake, at Rs 308.91 per share. The total transaction value stood at Rs 58.82 crore.
IRB Infrastructure reported mixed Q3FY26 results. Revenue declined, EBITDA improved, while profit after tax fell sharply due to a high base effect and exceptional items.
